RSS   Newsletter   Contact   Advertise with us

Director Ed Torr to leave Dechra Pharmaceuticals

Staff writer | Stoke on Trent, United Kingdom | January 30, 2014
Ed TorrDechra Pharmaceuticals, a veterinary pharmaceutical company, announced that Ed Torr is to step down as an executive director and will be leaving the company, effective January 31, 2014.
It is Dechra's intention to enter into a Consultancy Agreement with Mr. Torr later in the year.

Mr. Torr joined NVS as Sales Director in 1997 and was appointed Managing Director of Arnolds and Dales in 1998.

He was appointed Development Director in 2003 and Managing Director of Dechra Veterinary Products Europe in January 2008, following completion of the acquisition of VetXX.

In May 2012 on the completion of the acquisition of Eurovet Animal Health B.V., Mr. Torr reverted to his historical position within Dechra as Business Development Director.

Prior to joining the Group, Mr. Torr worked within the animal healthcare sector for a number of companies including ICI, Wellcome and Alfa Laval Agri.


 LATEST MOVES FROM United Kingdom 


MORE INSIDE POST